Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 76.1	$ 62.0
Accounts receivable, net	43.9	31.6
Inventories	21.7	17.3
Income tax receivable	1.8	0.9
Prepaid expenses and other current assets	7.7	13.1
Total current assets	151.2	124.9
Property, plant, and equipment, net	137.6	142.1
Operating lease right-of-use assets, net	20.9	23.7
Goodwill	443.7	450.1
Intangible assets, net	312.2	345.4
Deferred tax assets	0.1	0.1
Other assets	38.5	36.4
Total assets	1,104.2	1,122.7
Current liabilities
Accounts payable	26.9	17.6
Accrued liabilities and other	28.5	22.1
Current portion of long-term debt	5.6	2.5
Operating lease liabilities, current	4.0	3.8
Deferred revenue	3.4	2.0
Total current liabilities	68.4	48.0
Long-term debt	400.8	397.8
Deferred tax liabilities	62.0	71.6
Derivative instruments	1.3	6.3
Operating lease liabilities, non-current	20.8	24.7
Other liabilities	2.8	2.3
Total liabilities	556.1	550.7
Commitments and contingencies – Note 18
Shareholders' equity
Additional paid-in capital	699.6	693.7
Accumulated deficit	(145.3)	(123.8)
Accumulated other comprehensive income (loss)	(6.2)	2.1
Total shareholders' equity	548.1	572.0
Total liabilities and shareholders' equity	1,104.2	1,122.7
Class A common stock, $0.0001 par, 200,000,000 shares authorized at December 31, 2024 and 2023; shares issued and outstanding: 83,267,367 and 79,684,170 at December 31, 2024 and 2023, respectively
Shareholders' equity
Common stock	0.0	0.0
Convertible Class C common stock, $0.0001 par, 200,000,000 shares authorized at December 31, 2024 and 2023; shares issued and outstanding: 0 and 2,921,099 at December 31, 2024 and 2023
Shareholders' equity
Common stock	$ 0.0	$ 0.0